REQUEST A DEMO
Total
USD $0.00
Search more companies

Alwil Medical S.R.O. (Czech Republic)

Main Activities: Pharmacies and Drug Stores
Full name: Alwil Medical S.R.O. Profile Updated: November 11, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Alwil Medical S.R.O. is based in Czech Republic, with the head office in Usti nad Labem. The company operates in the Pharmacies and Drug Stores industry. The company was established on November 20, 1991. 6 - 9 (2024) employees currently work for Alwil Medical S.R.O.. From the latest financial highlights, Alwil Medical S.R.O. reported a net sales revenue increase of 28.03% in 2023. Its’ total assets recorded a negative growth of 24.95%. Alwil Medical S.R.O.’s net profit margin increased by 5.36% in 2023.

Headquarters
V Podhaji 776/30
Usti nad Labem; Ustecky; Postal Code: 40001

Contact Details: Purchase the Alwil Medical S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Alwil Medical S.R.O. report to view the information.
Outstanding Shares:
Purchase the Alwil Medical S.R.O. report to view the information.
Registered Capital:
Purchase the Alwil Medical S.R.O. report to view the information.
Incorporation Date:
November 20, 1991
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
30%
Purchase this report to view the information.
20%
Company Performance
Financial values in the chart are available after Alwil Medical S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
28.03%
Total operating revenue
27.15%
Operating profit (EBIT)
187.5%
EBITDA
131.76%
Net Profit (Loss) for the Period
188.32%
Total assets
-24.95%
Total equity
-23.81%
Operating Profit Margin (ROS)
8.04%
Net Profit Margin
5.36%
Return on Equity (ROE)
22.09%
Quick Ratio
-0.6%
Cash Ratio
-0.85%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?